Fundz

Squarex Pharmaceutical reported raising $25,000 in an initial SEC Form D filing, from an offering of $2 Million

PRIVATENov 22, 2022

Amount Raised

$25,000

$25,000 sold, per SEC Form D (first sale Oct 24, 2022)

Round Type

Pre-Seed

St. PaulHealthcare

Who to call at Squarex Pharmaceutical, and when

A new round usually means Squarex Pharmaceutical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Squarex Pharmaceutical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Squarex Pharmaceutical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Squarex Pharmaceutical. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Squarex Pharmaceutical

Location

1000 WESTGATE DRIVE, SUITE 1010

St. Paul, Minnesota, United States

About

Squarex is a late clinical-stage biopharmaceutical company focused on the development and the Company’s commercialization of therapeutic candidates to address large market opportunities. Squarex is initially focused on the prevention of recurrent cold sores (herpes labialis) and other infections caused by Herpes Simplex Virus 1 or Herpes Simplex Virus 2. The Company’s lead product candidate, SQX770, has successfully completed three clinical trials and shown significant efficacy in all three. Squarex’s drug SQX770 is unique.  A single topical application to the arm, (not the lip or face), has been shown in clinical trials to prevent cold sore outbreaks (oral herpes) in people with frequent outbreaks for 3 months.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Squarex Pharmaceutical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Squarex Pharmaceutical's next move

See what Strategic adds

Squarex Pharmaceutical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.